High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy

Indian Journal of Medical Microbiology

Volumn 27, Issue 1, 2009, Pages 48-50

  Ahmed, M ^a   Munshi, S ^a   Nessa, A ^a   Ullah, M ^a   Tabassum, S ^a   Islam, M ^a  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Anti hepatitis A virus (HAV); HAV seroprevalence; HAV vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY SCREENING; ARTICLE; BANGLADESH; CHILD; COST BENEFIT ANALYSIS; DECISION MAKING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; POPULATION; PREVALENCE; SEROPREVALENCE; SOCIOECONOMICS; URBAN AREA; VACCINATION;

EID: 59049088013     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Joshi N, Kumar N, Kumar A. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India. Trop Gastroenterol 2000;21:63-5.
2. Agboatwalla M, Isomura S, Miyake K, Yamashita T, Morishita T, Akram DS. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994;61:545-9.
3. Frosner GG, Papaevangelou G, Butler R, Iwarson S, Lindholm A, Courouce-Pauty A, et al. Antibody against hepatitis A in seven European countries: Comparison of prevalence data in different age groups. Am J Epidemiol 1979;110:63-9.
4. Kaw HW, Aschcavai M, Redekar AG. The persistence of IgM antibody after acute clinical hepatitis A. Hepatology 1984;4:933-6.
5. Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A in England: Implications for disease control. Epidemiol Infect 1994;113:113-20.
6. WHO. WHO position paper on hepatitis A vaccines. Wkly Epidemiol Rec 2000;75:38-44.
7. Mall ML, Rai RR, Philip M, Naik G, Parekh P, Bhawnani SC, et al. Seroepidemiology of hepatitis A infection in India: Changing pattern. Indian J Gastroenterol 2001;20:132-5.
8. Stapleton JT. Host immune response to hepatitis A virus. J Infect Dis 1995;171:S9-14.
9. Szmuners WF, Dienstag JL, Purcell RH, Steven CE, Wong DC, Ikram H, et al. The prevalence of antibody to hepatitis A antigen in various parts of the world: A pilot study. Am J Epidemiol 1977;106:392-8.
10. Dittman S. International congress on viral hepatitis A and B: Experience in education and prevention. Vaccine 2000;18:S1-2.
11. CDC. Recommendations and Reports. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep1996;45:1-30.